

          1. Known hypersensitivity to tocilizumab or its excipients

          2. Known active infections or other clinical condition that contraindicate tocilizumab
             and cannot be treated or solved according to the judgement of the clinician

          3. ALT / AST> 5 times the upper limit of the normality

          4. Neutrophils <500 / mmc

          5. Platelets <50.000 / mmc

          6. Bowel diverticulitis or perforation
      